Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
4
Number of overlapping holdings
17.4%
% of PPH's 26 holdings also in OZEM
19.0%
% of OZEM's 22 holdings also in PPH
Overlap by Weight
Sector Drift (PPH minus OZEM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 13.8% | 16.9% | 13.8% |
 |
NOVO-NORDISK A/S-SPONS ADR | 4.4% | 16.2% | 4.4% |
|
PFIZER INC | 4.4% | 3.5% | 3.5% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.1% | 3.1% | 3.1% |
Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to OZEM
|
JOHNSON & JOHNSON | 7.2% |
|
ABBVIE INC | 6.3% |
 |
NOVARTIS AG-ADR | 5.8% |
|
CENCORA INC | 5.8% |
|
MCKESSON CORP | 5.6% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 5.1% |
 |
SANOFI-AVENTIS-ADR | 5.0% |
|
MERCK & CO. INC. | 4.8% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 4.8% |
|
ZOETIS INC | 4.7% |
PPH Underweight Relative to OZEM
|
NOVO-NORDISK A/S-SPONS ADR | -11.8% |
|
ROCHE HOLDING LTD | -4.9% |
|
CHUGAI PHARMACEUTICAL CO LTD | -4.7% |
|
ZEALAND PHARMA A/S | -4.6% |
|
VIKING THERAPEUTICS, INC. | -4.1% |
 |
INNOVENT BIOLOGICS, INC. | -3.6% |
|
ALTIMMUNE, INC. | -3.6% |
|
ELI LILLY & CO | -3.1% |
 |
HANMI PHARM CO LTD | -3.1% |
|
AMGEN INC | -3.0% |